To Disclose a Child Sexual Abuse Within Child & Adolescent Psychiatry Services

NCT ID: NCT06495502

Last Updated: 2024-07-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

90 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-01-01

Study Completion Date

2026-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Mental health professionals investigating child sexual abuse (CSA) among children and adolescents is a major public health challenge. Many studies have shown the obstacles to disclose, with professionals having difficulties to address this issue and survivors having difficulties to disclose. Many children, old enough to tell what happened to them, would disclose this traumatic event only many years after, but they suffer from psychiatric and/or somatic disorders meanwhile. CSA survivors presenting psychiatric symptoms very often receive a psychiatric treatment within child \& adolescent psychiatric (CAP) departments.

The investigators aim to better understand what is at stakes around the issue of disclosure of CSA by teenagers within CAP services, so to draw concrete implications to improve investigation efficacy and disclosure support by mental health professionals. To date, no study has ever explored these issues of investigating and disclosing CSA in CAP services. Qualitative methods are quite relevant here, aiming as they do, to in-depth explore complex issues, through the lived experience of the stakeholders.

The main objective of this study is to explore the lived experience of disclosing CSA among (i) adolescents and young adults followed in a CAP service, (ii) parents, and (iii) child \& adolescent mental health professionals working in CAP services who have experienced a CSA disclosure. Crossing perspectives will bring answers to the complex question: "how to disclose a CSA within a CAP service?" and will lead to concrete implications to improve treatment of children and adolescents with an history of CSA.

It is an exploratory qualitative multi-center design following the IPSE approach - Inductive Process to analyze the structure of lived experience-.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Mental health professionals investigating child sexual abuse (CSA) among children and adolescent is a major public health challenge. Many studies have shown the obstacles to disclose, with professionals having difficulties to address this issue and survivors having difficulties to disclose. Many children, old enough to tell what happened to them, would disclose this traumatic event only many years after, but they suffer from psychiatric and/or somatic disorders meanwhile. CSA survivors presenting psychiatric symptoms very often receive a psychiatric treatment within child \& adolescent psychiatric (CAP) departments. This follow-up is to be considered as an opportunity for them to disclose. Yet, according to the current literature, 20% of women and 39% of men would not disclose the CSA. Among children and adolescents, disclosure rate is estimated between 16 and 25%. Reducing disclosure delay and improving the quality of mental health professionals support around the issue of disclosure and its outcomes (individual, family, forensic), could improve survivors prognostic.

The investigators aim to better understand what is at stakes around the issue of disclosure of CSA by teenagers within CAP services, so to draw concrete implications to improve investigation efficacy and disclosure support by mental health professionals. To date, no study ever explored these issues of investigating and disclosing CSA in CAP services. Qualitative methods are quite relevant here, aiming as they do, to in-depth explore complex issues, through the lived experience of the stakeholders.

The main objective of this study is to explore the lived experience of disclosing CSA among (i) adolescents and young adults followed in a CAP service, (ii) parents, and (iii) child \& adolescent mental health professionals working in CAP services who have experienced a CSA disclosure. Crossing perspectives will bring answers to the complex question: "how to disclose a CSA within a CAP service?" and will lead to concrete implications to improve treatment of children and adolescents with an history of CSA.

It is an exploratory qualitative multi-center design following the IPSE approach - Inductive Process to analyze the structure of lived experience-. IPSE is a five-steps process: 1) set up a research group, 2) ensure the originality of the research, 3) organize recruitment and sampling intended to optimize exemplarity, 4) collect data that enable entry into the subjects 'experience, and 5) analyze the data. This final stage is composed of one individual descriptive phase, followed by two group phases: i) define the structure of the lived experience, and ii) translate the findings into concrete proposals that make a difference in care.

1 - Patients : i. be in a well-identified care path ii. Age: 12-25 years old iii. have experienced CSA iv. Child \& adolescent psychiatry treatment prior to majority and after CSA, regardless the reason for this treatment v. No acute symptoms 2. Parents i. child on a well-identified care path ii. child victim of CSA iii. Child disclosure during child \& adolescent psychiatry treatment iv. not being the perpetrator in case of intrafamilial CSA perpetrated by the mother or the father (the other parent could be included).

3\. Child \& adolescent mental health professionals i. have experienced, directly or indirectly, at least one situation of CSA disclosure by a minor patient.

This is a qualitative study, the number of participants required cannot be known beforehand, as it will be determined by the data saturation, based on the principle of theoretical sufficiency.

However, our experience in qualitative research allows us to propose a minimum of 30 participants per subgroup, for a total of 90 participants. This sample size will provide better visibility of our work and will ensure theoretical sufficiency.

Recruitment by local coordinators/co-investigators Data collection will be taken place within the five French departments.

The multicentric aspect is only to facilitate recruitment and to ensure data saturation but, in a qualitative study, it does not impact the quality and originality of the findings Intentional and non-probabilistic sampling strategy known as "Purposive Sampling" in maximum variation, that is to select exemplary/archetypal situations reflecting a variety of experiences, in order to obtain rich and diverse narratives, according to the principle of maximum variation. This is the technique of choice for sampling in qualitative research.

Data will be collected through semi-structured interviews by qualitative health researchers

All participants will be fully informed - orally and in writing- about the research and will express their non-opposition to participate in such research.

Non-opposition of the participants collected by the researcher and confirmed on the information and non-opposition form signed before any data collection and interview.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Child Sexual Abuse

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

patients

i. be in a well-identified care path ii. Age: 12-25 years old iii. have experienced CSA iv. Child \& adolescent psychiatry treatment prior to majority and after CSA, regardless the reason for this treatment v. No acute symptoms

semi-structured interview

Intervention Type OTHER

Semi-structured interviews by qualitative health researchers

Parents

i. child on a well-identified care path ii. child victim of CSA iii. Child disclosure during child \& adolescent psychiatry treatment iv. not being the perpetrator in case of intrafamilial CSA perpetrated by the mother or the father (the other parent could be included).

semi-structured interview

Intervention Type OTHER

Semi-structured interviews by qualitative health researchers

child & adolescent mental health professionals

i. have experienced, directly or indirectly, at least one situation of CSA disclosure by a minor patient.

semi-structured interview

Intervention Type OTHER

Semi-structured interviews by qualitative health researchers

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

semi-structured interview

Semi-structured interviews by qualitative health researchers

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adolescents and young adults from four child \& adolescent psychiatric services in Argenteuil (SUPADO), Rouen, Lyon, Colombes and Rennes. T
* in a well-identified care path
* Age: 12-25 years old
* have experienced Child Sexual Abuse (CSA)
* Child \& adolescent psychiatry treatment prior to majority and after CSA, regardless the reason for this treatment
* Parents with a Son/daughter on a well-identified care path, victim of CSA, with a disclosure during child \& adolescent psychiatry treatment
* Child \& adolescent mental health professionals

Exclusion Criteria

* for adolescents, acute symptoms
* for parents, in the situation of intrafamily CSA perpetrated by a parent, this parent will be excluded
Minimum Eligible Age

12 Years

Maximum Eligible Age

25 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Anne Revah-Levy

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Anne Revah-Levy

Professor of child & adolescent psychiatry

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jordan Sibeoni, MD PhD

Role: PRINCIPAL_INVESTIGATOR

Centre Hospitalier Victor Dupouy

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hôpital Louis Mourier

Colombes, Hauts De Seine, France

Site Status RECRUITING

Pôle Hospitalo-Universitaire de Psychiatrie de l'enfant et l'adolescent de Rennes

Rennes, Ille-et-Vilaine, France

Site Status RECRUITING

Hopital Femme Mère Enfant, Hospices Civils de Lyon

Bron, Rhone, France

Site Status RECRUITING

CHU Rouen/CH Rouvray

Rouen, Seine Maritime, France

Site Status RECRUITING

CHVictorDupouy

Argenteuil, Île-de-France Region, France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jordan Sibeoni, MD PhD

Role: CONTACT

0033134232598

Anne Revah-Levy, MD PhD

Role: CONTACT

0033134232598

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Caroline Dubertret, MD PhD

Role: primary

01 47 60 61 62

Solenne Kermarrec, MD PhD

Role: primary

02 99 28 43 21

Pierre Fourneret, MD PhD

Role: primary

0 825 08 25 69

Malaika Lasfar, MD

Role: primary

02 32 88 89 90

Jordan Sibeoni, MD PhD

Role: primary

0033134232598

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CHVictorDupouy

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

My Life and My Experiences Project
NCT06821178 RECRUITING NA